Brandywine Realty Trust

Brandywine Realty Trust (BDN) Market Cap

Brandywine Realty Trust has a market capitalization of .

No quote data available.

CEO: Gerard H. Sweeney

Sector: Real Estate

Industry: REIT - Office

IPO Date: 1986-07-24

Website: https://www.brandywinerealty.com

Brandywine Realty Trust (BDN) - Company Information

Market Cap: -|Sector: Real Estate

Company Profile

Brandywine Realty Trust (NYSE: BDN) is a prominent, publicly traded Real Estate Investment Trust (REIT) operating across the United States. The company stands as a full-service, integrated real estate enterprise, primarily concentrating its operations in key markets such as Philadelphia, Austin, and Washington, D.C. Brandywine actively acquires, develops, leases, and manages a diverse portfolio of urban, town center, and transit-oriented properties. As of December 31, 2020, this extensive portfolio comprised approximately 175 properties, totaling 24.7 million square feet, a figure which excludes assets held for sale. At its core, Brandywine aims to shape, connect, and inspire the environment around it, achieving this through its specialized expertise, the robust relationships it cultivates, its engagement with the communities it serves, and the lasting legacy it collectively builds.

Analyst Sentiment

33%
Underperform

From 5 Active Polls

1Y Forecast: $3.00

▲ +0.0% Potential Upside

Consensus Target Metrics

Low Bound

$3

Median

$3

High Bound

$3

Average

$3

Price & Moving Averages

Loading chart...

🎯 Wall Street Analyst Intelligence Report

1-Year structural target targets, chart projections, and sentiment maps.

Average 1Y Target
$3.00
▼ -1.32% Upside
Low Target
$3.00
-1% Risk
Median Target
$3.00
-1% Mid
High Target
$3.00
-1% Max

Consensus Trend Projection

Trailing closures vs. 12-month metrics map.

Analyst Vote Distribution

Aggregate institutional coverage sentiment weights.

Sentiment volume allocation data unavailable.

Historical valuation matrix unavailable.

📘 Full Research Report

ℹ️

AI-Generated Research: This report is for informational purposes only.

📘 BRANDYWINE REALTY TRUST REIT (BDN) — Investment Overview

🧩 Business Model Overview

Brandywine Realty Trust operates as a diversified real estate owner focused on leasing and managing office and life-science oriented properties across select Mid-Atlantic markets, with an emphasis on Philadelphia and surrounding growth corridors. The value chain is straightforward: the company acquires and develops/renovates buildings, leases space to corporate tenants, and converts tenant demand into recurring cash flow through base rents plus tenant recoveries. Over time, property-level redevelopment (including repositioning older assets into modern office/life-science use cases) aims to preserve tenant relevance, support renewal activity, and improve average rent potential.

💰 Revenue Streams & Monetisation Model

  • Core recurring rental revenue: contractual lease payments from office and life-science space, typically supported by lease structures that include rent escalators over time.
  • Tenant recoveries and reimbursements: pass-throughs for operating expenses (e.g., property taxes, common-area maintenance), which can partially protect operating margins against cost inflation.
  • Ancillary income: parking and other property services that add incremental, often lower-volatility revenue tied to occupancy and tenant presence.
  • Repositioning and development economics: gains are pursued through higher-quality space delivery, improved lease terms, and potential value creation from redevelopment and leasing spreads over the cycle.

Margin drivers primarily include occupancy/lease-up efficiency, lease spreads versus market, recoverability of operating costs, and capital discipline (redevelopment intensity versus expected rental yield). In REITs such as BDN, the monetisation model is ultimately cash-flow conversion through stable leasing and cost control, supported by the REIT’s ability to finance and execute property upgrades.

🧠 Competitive Advantages & Market Positioning

BDN’s moat is best characterized as location-and-asset stickiness with property-level switching costs, reinforced by redevelopment capabilities in specific demand pockets.

  • Switching costs (tenant-level): office and life-science tenants face meaningful relocation frictions—buildout costs, technology infrastructure alignment, workforce considerations, and disruption risk. BDN can capture lease renewals and incremental demand when buildings remain operationally “ready” for tenant requirements (layout, systems, and amenity support).
  • Geographic concentration with submarket expertise: BDN focuses on Mid-Atlantic markets where demand can be more idiosyncratic than in mega-metro coastal markets. Concentration can improve leasing execution and operational focus versus competitors stretched across less coherent portfolios.
  • Redevelopment as an economic barrier: upgrading older assets into modern office/life-science-ready product creates a practical barrier to quick imitation because competitors must either (a) buy comparable buildings at scale or (b) fund similar capex programs—both time-consuming and capital-intensive.

COMPETITIVE BENCHMARKING

  • SL Green Realty (SLG) / Vornado Realty (VNO): more concentrated exposure to New York City core office demand and submarket dynamics. Their competitive center of gravity differs from BDN’s Mid-Atlantic footprint.
  • Alexandria Real Estate (ARE): deeper specialization in life science-enabled space, supported by a national platform approach. BDN competes in life-science adjacent demand through repositioning and tenant services, but with a more regionally concentrated portfolio.
  • Office REIT peers with broader regional spreads: these players may compete for tenants on amenities, lease incentives, and capital availability, while BDN’s differentiation tends to rest on property execution in its core markets rather than on scale across every major metro.

🚀 Multi-Year Growth Drivers

  • Life-science and modern workplace repositioning: structural tenant preference for higher-quality building systems, flexible layouts, and amenity-enabled environments supports incremental leasing value when assets are upgraded to match demand requirements.
  • Supply management in key submarkets: in markets where new competitive deliveries are limited or slow to complete, refurbished space can capture disproportionate leasing activity relative to older, non-upgraded stock.
  • Operating leverage from improved occupancy and expense management: as occupancy rises and lease-up stabilizes, fixed operating costs and leasing/marketing spend can create better per-space economics.
  • Rent resilience from lease structure design: lease contractual terms and recovery frameworks influence cash-flow durability through the cycle.

Over a 5–10 year horizon, the total addressable market is driven less by broad office growth and more by the share shift toward upgraded space, including life-science oriented facilities and workplace requirements that favor modernized assets. BDN’s growth math depends on maintaining competitive positioning within those narrower demand pockets and executing redevelopment without impairing balance-sheet flexibility.

⚠ Risk Factors to Monitor

  • Capital intensity and execution risk: repositioning requires timely capex and high-quality delivery; underperformance can compress returns and extend lease-up timelines.
  • Office demand cyclicality and tenant credit risk: leasing velocity, renewals, and concessions can deteriorate quickly when macro conditions weaken; tenant defaults can raise vacancy and cash-flow uncertainty.
  • Financing and interest rate sensitivity: REIT returns are affected by refinancing conditions, debt maturities, and the cost of capital; balance-sheet stress can force asset sales or restrictive capital allocation.
  • Concentration risk: Mid-Atlantic focus concentrates exposure to specific local market drivers (employment growth, development pipelines, and tenant consolidation decisions).
  • Regulatory and environmental liabilities: property taxes, permitting, and environmental compliance can affect redevelopment timing and operating costs.

📊 Valuation & Market View

In the REIT sector, equity valuation typically reflects cash-flow durability and net asset value-like assessments, with investors focusing on metrics such as FFO/AFFO, property-level income quality, debt maturity ladders, and implied capitalization rates. Multiple compression or expansion is generally driven by:

  • Interest rate expectations and credit conditions (discount rates and refinancing spreads).
  • Occupancy and lease-up trajectories (cash-flow confidence).
  • Redevelopment outcomes (ability to translate capex into sustainable rent and occupancy).
  • Balance-sheet risk (leverage, liquidity, and debt maturity profile).

For BDN, the market view often hinges on whether redevelopment and leasing strategies can sustain a competitive cost-of-space proposition and protect long-term cash-flow generation in its operating footprint.

🔍 Investment Takeaway

BDN’s long-term case rests on tenant-level switching costs created by relocation frictions, supported by redevelopment-driven differentiation in select Mid-Atlantic demand pockets. The investment outlook is most compelling when the company demonstrates disciplined execution—delivering upgraded space that preserves leasing momentum and supports AFFO durability—while maintaining balance-sheet flexibility through credit cycles.


⚠ AI-generated — informational only. Validate using filings before investing.

📊 AI Financial Analysis

Powered by StockMarketInfo
Earnings Data: Q Ending 2026-06-30

"BDN reported Q2 2026 revenue of $128.92m (+1.52% QoQ; +6.87% YoY). Net income was -$31.41m versus -$48.59m in Q1 2026 (+35.36% QoQ improvement in losses) and -$88.94m in Q2 2025 (YoY improvement: losses narrowed by ~64.66%). Margins were volatile: gross margin swung negative to -14.8% in Q2 2026 (down from -18.5% in Q1 2026 and far below the +62% gross margin seen in prior 2025 quarters). Operating income was +$19.39m in Q2 2026 (operating margin +15.0%), while net margin remained deeply negative at -24.4% due to large net other expenses (notably -$50.91m totalOtherIncomeExpensesNet). Balance sheet resilience appears mixed. Total assets were $3.54b in Q2 2026, roughly flat vs Q1 2026 ($3.59b), but stockholders’ equity declined to $0.70b (down from $0.74b). Net debt remained very high at ~$2.61b, and retained earnings were sharply negative (-$2.52b), indicating ongoing cumulative losses. On cash flow, the provided cash flow line items appear inconsistent (Q2 2026 operating cash flow and free cash flow are reported as 0), so cash-flow quality signals are limited. Shareholder returns are weak: the stock is down -20.43% over 1 year with no buyback/dividend activity reported in Q2 (dividends paid 0). Overall, the turnaround in net income is encouraging, but margin instability and financial leverage weigh on the outlook."

Revenue Growth

Neutral

Revenue rose modestly QoQ (+1.52%) to $128.92m and accelerated YoY (+6.87%), suggesting improving top-line traction despite quarter-to-quarter volatility.

Profitability

Neutral

Net income improved QoQ (losses -$48.59m to -$31.41m; ~+35.36%) and improved YoY (-$88.94m to -$31.41m; ~+64.66%). However, gross margin deteriorated to -14.8% in Q2 2026 from -18.5% in Q1 and reversals from strongly positive 2025 gross margins indicate unstable cost/financial performance. Net margin remains poor at -24.4%.

Cash Flow Quality

Neutral

Net income is negative, but cash flow reporting for Q2 2026 shows operating cash flow and free cash flow as 0, limiting confidence in cash generation. Prior quarters showed meaningful swings (e.g., Q1 OCF +$10.2m; Q4 FCF +$18.9m), but Q2 data is not decision-useful.

Leverage & Balance Sheet

Neutral

Total assets were stable QoQ ($3.59b to $3.54b), but equity fell ($0.74b to $0.70b) and retained earnings remain deeply negative. Net debt stayed very high (~$2.61b), implying limited balance-sheet flexibility.

Shareholder Returns

Neutral

Price momentum is negative: 1Y change is -20.43% (no >20% momentum tailwind). Dividend yield is ~2.52% per ratios, but Q2 2026 dividends paid are shown as 0 and net losses persist, reducing confidence in total return durability.

Analyst Sentiment & Valuation

Caution

Consensus price target is $3 versus current price $2.96, implying limited upside on valuation. Without >20% 1Y momentum, sentiment/valuation support appears modest.

Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.

Fundamentals Overview

Loading fundamentals overview...

BDN delivered Q2 2026 FFO of $0.13/share, above management guidance but $0.01 below consensus, with speculative revenue at $18.3M and 99% achievement of revised midpoint. The main operating positives were tenant retention (85% in Q2) lifting the full-year retention midpoint to 51%–53%, strong Philadelphia CBD leasing (54% of new CBD/University City leases at Brandywine properties), and improved tour conversion metrics. Liquidity strengthened as ~$208M of asset sales closed and the $192M line of credit balance was paid off; quarter-end cash was $35M. However, Austin remains a material drag: 67% occupied and >400 bps reduction to company occupancy, tied to 405 Colorado held for sale/transition. Management’s outlook depends on continued sales execution (raising 2026 disposition target to $305M, all expected by end of Q3) plus recapitalization of ATX projects, with one-time buyback extinguishment risk and elevated leverage until remaining development revenue ramps.

AI IconGrowth Catalysts

  • Speculative revenue outperformance: $18.3M spec revenue, driven primarily by Philadelphia CBD and University City
  • Philadelphia CBD outperformance in leasing: 54% of new leases in CBD/University City signed at Brandywine properties in 1H26
  • Monitoring conversion projects totaling >5.1M sq ft (~11% of Philadelphia office inventory) to improve future leasing momentum
  • Tenant retention strength: raised full-year retention midpoint to 51%–53% after 85% retention in Q2 driven by unbudgeted renewals/expansions
  • Uptown ATX redevelopment momentum ahead of 2027 IBM expiration: >1.1M sq ft pipeline; 157k sq ft first building targeting delivery in 4Q27 with targeted cash yield >8%

Business Development

  • Leasing momentum at 1 UPTOWN/ATX: IBM expiration in 2027 driving redevelopment plans; executives referenced strong pipeline build and multi-floor tenant discussions tied to lease negotiations
  • Radnor Hotel development: 121-room hotel opened May 2026 adjacent to Radnor life science/office portfolio and Penn Medicine campus; universities/colleges within 5-mile radius used as amenity draw
  • Sierra Center life science/tenant market engagement: hosted event with Pennsylvania Governor Josh Shapiro and state officials to announce $125M Innovate 2.0 Penn financing program for life sciences

AI IconFinancial Highlights

  • Q2 FFO: $0.13 per diluted share; ahead of management guidance, $0.01 below consensus
  • Q2 net loss: $31M, or ($0.18) per share
  • Speculative revenue: exceeded plan by $1M (guidance midpoint) and achieved 99% of revised speculative revenue at midpoint
  • FFO guidance: maintained $0.55 full-year midpoint; narrowed full-year FFO range
  • Tenant retention: Q2 retention 85% leading to full-year midpoint retention raised to 51%–53%
  • Mark-to-market: GAAP mark-to-market of 1.5% (cash mark-to-market declined during the quarter)
  • Leverage and debt metrics: Q2 annualized combined net debt/EBITDA 9.0x; core net debt/EBITDA 8.1x; debt service and interest coverage 1.7x
  • Q3 guidance FFO range: $0.13–$0.15 (core FFO range); joint venture FFO contribution expected to be breakeven in Q3

AI IconCapital Funding

  • Asset sales: ~$208M closed to date; remaining transactions under agreement (~$97M remaining to reach $305M total) expected to close in Q3
  • Sales target: raised 2026 sales guidance to $305M (from $280M–$300M business plan), with all $305M expected to close by end of Q3
  • Line of credit: $192M sale proceeds used to pay off line of credit balance; no outstanding balance at quarter end; $35M cash on hand
  • Buyback plan: intent to repurchase bonds starting as early as this quarter; equity buybacks limited to ~5%–10% of net proceeds until leverage/credit targets achieved
  • Construction/refinancing: repaid $178M consolidated construction loan scheduled to mature July 2026 in June; funded via $90M 7-year secured financing (fixed all-in rate 5.8%) plus use of unsecured line of credit
  • Leverage expectation: year-end core net debt/EBITDA projected 8.0x–8.4x

AI IconStrategy & Ops

  • Portfolio operating changes: removed 4 properties from core portfolio classified as held for sale; ~775k sq ft (~91.5% occupied); excluded from quarter-end operating statistics
  • Core additions: added 250 King of Prussia Road (168k sq ft life science) to core portfolio after stabilization in June
  • Leasing operations: trailing 4-quarter tour conversion improved—53% of tours convert to lease proposal; 41% of proposals convert to executed leases (above historical average)
  • Pipeline: operating portfolio leasing pipeline up 13% (~220k sq ft) vs Q1; just shy of 2M sq ft total, including ~456k sq ft in advanced negotiations
  • Austin headwind: Austin at 67% occupied created >400 bps drop in overall company occupancy; quarter-end Austin occupancy impacted by 3.7% due to 405 Colorado held for sale then closed
  • CAD payout: Q2 CAD payout ratio 103%; expects 70%–90% for remainder of 2026 as FFO improves

AI IconMarket Outlook

  • Q3 property-level operating income guidance: ~$69.5M (about $3M below Q2), reflecting NOI reduction from held-for-sale assets that closed in July
  • Radnor Hotel impact: expected $1.2M quarter-over-quarter increase in Q3 due to full-quarter effect (commenced May)
  • Stabilized asset impact: 250 King of Prussia Road stabilization in June expected to provide full-quarter effect in Q3
  • Full-year core FFO range maintained: $0.55 midpoint; range narrowed (exact endpoints not fully visible, but midpoint reaffirmed)
  • Year-end occupancy/lease: executives reiterated year-end occupancy and lease percentage targets held, expecting positive full-year net absorption for first time in several years

AI IconRisks & Headwinds

  • Austin occupancy lag: 67% occupied and >400 bps drag on overall occupancy; 405 Colorado contributed to quarter-end occupancy pressure before disposition closure
  • Life sciences demand recovery described as positive but not yet accelerating at desired pace; durability noted but timing of lease conversions remains uncertain
  • Potential one-time costs: bond buybacks may trigger one-time debt extinguishment charges not included in current FFO guidance
  • Leverage ratios remain elevated until revenue ramps from remaining development projects (notably 3.15k Market) and as asset sales/development recapitalizations progress

Q&A: Analyst Interest

  • 3.15k Market (3.15 thousand sq ft) tenancy mix and life-science momentum: Management said the building has a multi-floor client in advanced negotiations, expecting “additional momentum.” On life science, they cited $125M “Innovate 2.0 Penn” financing announced with Governor Shapiro, aimed at accelerating life-science capital structures and tenant graduation pace.
  • Austin disposition demand and oversupply context: Management described strong bid activity for 405 Colorado, with “north of $700/sq ft” pricing aligned to assumed guidance and a favorable WAL/leasing profile despite 5–6 year stabilization and 5M sq ft total vacancy. On Solaris, they said high probability of a cap-rate transaction in 60–90 days despite temporary apartment overbuilding.
  • Buyback vs debt repayment framework and timing: Management framed the ~5%–10% equity buyback as an adjunct to maintain “earnings neutrality” through the sales program while primary focus remains investment grade deleveraging. They emphasized minimizing interest on ~$900M high-8% coupon bonds and argued shares are relatively undervalued versus cap-rate pricing context.

Sentiment: MIXED

Note: This summary was synthesized by AI from the BDN Q2 2026 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.

Loading financial data and tables...
© 2026 Stock Market Info — Brandywine Realty Trust (BDN) Financial Profile